KIDS compared with IMUX: revenue, margins and what each company keeps, and the suppliers and customers both name

KIDSOrthopediatrics Corp

Mkt capRevenueRevenue

IMUXImmunic, Inc.

Mkt capRevenueRevenue

Compare

KIDSOrthopediatrics Corp

IMUXImmunic, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

KIDS

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q3 FY26—▲+29.30%—

Q2 FY26±19.2%▲+6.85%×0.35

Q1 FY26±28.5%▲+3.78%×0.13

Feb 27 '26±21.8%▲+7.76%×0.36

IMUX1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±18.3%▲+9.79%×0.54

= impliedKIDS realized, solidIMUX realized, hatchedOne scale, both sides: full bar = 30%× = |realized| ÷ impliedSource: market data

KIDSOrthopediatrics Corp

30.37· pre 30.37· delayed

Mkt cap$794.5MRevenue$73MQ3 FY26Revenue$236MFY25

IMUXImmunic, Inc.

7.35· pre 7.45· delayed

Pre-marketNov 2 '26delayed

Mkt cap$102.5MRevenue—Revenue—

Compare

Pre-marketNov 2 '26delayed

KIDSOrthopediatrics Corp

IMUXImmunic, Inc.

30.37pre 30.37delayed

Price

7.35pre 7.45delayed

$794.5M

Mkt cap

$102.5M

Q3 FY26$73M

Revenue

—

FY25$236M

Revenue

—

KIDS30.37vsIMUX7.35Pre-marketNov 2 '26delayed